Home » Topics » Regulatory » Patents

Patents
RSS

Otsuka reveals matrix metalloproteinase inhibitors

May 31, 1996

Merck & Co. reveals protein farnesyltransferase-inhibiting analogues

May 31, 1996

Ruthenium complexes revealed by Procept

May 31, 1996

Zeneca claims prostaglandin E antagonists

May 31, 1996

Merck Frosst Canada reveals cyclooxygenase type 2 (COX-2) inhibitors

May 31, 1996

Di-tert-butylphenol compounds from Proctor & Gamble

May 31, 1996

Bayer announces formulation of antibacterial agents

May 31, 1996

Retinoid antagonists revealed by Eisai

May 31, 1996

New bradykinin antagonists from Sanofi Winthrop

May 31, 1996

Astra reveals analgesic and immunosuppressive agents

May 31, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...